Rycarfa 50 mg tablets for dogs
Rycarfa 50 mg tablets for dogs
Authorised
- Carprofen
Product identification
Medicine name:
Rycarfa 50 mg tablets for dogs
RYCARFA 50 MG COMPRIMES POUR CHIENS
Active substance:
- Carprofen
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Carprofen50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AE91
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Blister (OPA/Al/PVC-Al): 20 tablets (10 tablets/blister) in a box
- Blister (OPA/Al/PVC-Al): 50 tablets (10 tablets/blister) in a box
- Blister (OPA/Al/PVC-Al): 100 tablets (10 tablets/blister) in a box
- Blister (OPA/Al/PVC-Al): 500 tablets (10 tablets/blister) in a box
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- Krka d.d. Novo Mesto
- Tad Pharma GmbH
- Krka-Farma d.o.o.
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/9289557 3/2013
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0316/002
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Italy
-
Netherlands
-
Norway
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
French (PDF)
Published on: 7/04/2022
How useful was this page?:
